Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosell

Showing results (211-220 of 265) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutationsM Monzó, R Rosell, J J Sánchez, et al.
British Journal of Cancer|October 15, 2009
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancerS Novello, G V Scagliotti, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancerC Camps, E Felip, J M Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trialsE Felip, B Massuti, C Camps, et al.
Advances in Medical Sciences|January 24, 2014
Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patientsA Szymanowska-Narloch, E Jassem, M Skrzypski, et al.
Thrombosis Research|February 5, 2014
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL studyR Lecumberri, G López Vivanco, A Font, et al.
Biological Psychiatry|May 4, 2010
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patientsDaniel R Rosell, Judy L Thompson, Mark Slifstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2011
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsT Reiman, R Lai, A S Veillard, et al.
Psychiatry Research. Neuroimaging|October 27, 2019
Neuroimaging predictors of response to cognitive remediation and social skills training: A pilot study in veterans with schizophreniaMargaret M McClure, Fiona S Graff, Joseph Triebwasser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Pageof 27

Showing results (211-220 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutationsM Monzó, R Rosell, J J Sánchez, et al.
British Journal of Cancer|October 15, 2009
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancerS Novello, G V Scagliotti, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancerC Camps, E Felip, J M Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trialsE Felip, B Massuti, C Camps, et al.
Advances in Medical Sciences|January 24, 2014
Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patientsA Szymanowska-Narloch, E Jassem, M Skrzypski, et al.
Thrombosis Research|February 5, 2014
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL studyR Lecumberri, G López Vivanco, A Font, et al.
Biological Psychiatry|May 4, 2010
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patientsDaniel R Rosell, Judy L Thompson, Mark Slifstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2011
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsT Reiman, R Lai, A S Veillard, et al.
Psychiatry Research. Neuroimaging|October 27, 2019
Neuroimaging predictors of response to cognitive remediation and social skills training: A pilot study in veterans with schizophreniaMargaret M McClure, Fiona S Graff, Joseph Triebwasser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trialR Rosell, U Gatzemeier, D C Betticher, et al.
Pageof 27